Sign in
← Compounds

ENDO-205

peptide · comparatorInvestigational

Non-hormonal precision peptide targeting endo lesions (pipeline)

Summary

PIPELINE — first-in-class non-hormonal "precision peptide" for endometriosis (EndoCyclic Therapeutics). Designed to eliminate endo lesions directly rather than suppress hormones. FDA IND cleared; entering human trials. Not yet available — a watch-list entry, not a protocol.

How it works

  • Targeted elimination of endometriotic lesions (non-hormonal, preclinical)

Dosing

    Cycling

      Side effects

      common: []
      warnings: ["Investigational — efficacy/safety not established in humans"]

      Used for

      No condition evidence rows yet.

      Legal / compounding

      Investigational

      Legal status is a hard gate: non-compoundable or delisted agents cannot be filled and are blocked from protocol export. Keep 503A status current.